A Japanese research team has demonstrated in rat experiments that stem cells from human primary tooth pulp may help treat ...

Cerebral palsy is a condition usually caused by brain damage before or during birth, resulting in impaired posture and movement. Early symptoms are typically subtle, which may delay diagnosis until ...

A first-in-human trial shows the feasibility and safety of delivering placenta-derived stem cells during prenatal ...

A first-in-human, phase I single-arm trial has found that in-utero treatment of myelomeningocele, the most severe form of spina bifida, using allogeneic live stem cells was both feasible and ...

China has stunned the global medical community with a revolutionary cure for Type 2 diabetes, offering hope to millions ...

Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...

Six pregnant women participated in a small trial in which placenta-derived stem cells were applied to fetal spinal cords and the treatment was found to be safe.

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

A Phase I clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery ...

The global stem cell therapy market is projected to experience robust growth, with an expected annual growth rate of 20% by 2029. Key drivers behind this expansion include a favorable investment ...